KG&L Capital Management LLC Sells 295 Shares of Colgate-Palmolive (NYSE:CL)

KG&L Capital Management LLC lowered its holdings in shares of Colgate-Palmolive (NYSE:CL) by 10.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 2,449 shares of the company’s stock after selling 295 shares during the period. KG&L Capital Management LLC’s holdings in Colgate-Palmolive were worth $223,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in CL. Union Bancaire Privee UBP SA purchased a new position in shares of Colgate-Palmolive in the fourth quarter valued at about $32,000. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive in the 3rd quarter worth approximately $42,000. Synergy Asset Management LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $49,000. Capital Performance Advisors LLP purchased a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $53,000. Finally, Prospera Private Wealth LLC bought a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $64,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Trading Down 4.7 %

Colgate-Palmolive stock opened at $86.64 on Friday. Colgate-Palmolive has a one year low of $82.68 and a one year high of $109.30. The business’s fifty day moving average is $91.35 and its 200 day moving average is $97.17. The stock has a market capitalization of $70.78 billion, a PE ratio of 24.82, a price-to-earnings-growth ratio of 3.70 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.27% and a return on equity of 405.81%. During the same quarter in the previous year, the company posted $0.87 EPS. On average, sell-side analysts predict that Colgate-Palmolive will post 3.58 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.31%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.34% of the company’s stock.

Analyst Ratings Changes

CL has been the topic of a number of research analyst reports. Royal Bank of Canada reissued a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday. JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. Stifel Nicolaus reduced their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a report on Friday, January 17th. Wells Fargo & Company lowered their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Finally, UBS Group dropped their target price on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $102.00.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.